Celgene Investments & Fund Profile

Overview

Biopharmaceutical company developing therapies for cancer and inflammation.

Founded

1986

Deals · 12mo

0

Links

Website LinkedIn X (Twitter)

Stage focus

Series A

Series B

Geographic focus

United States

Sector focus

Biotechnology

Medical

Investment portfolio

60rounds

LedParticipated

NAME	DATE	SIZE
Cyteir Therapeutics	Oct 2019Participated	$40 MSeries B
Anokion	Sep 2019Participated	$40 MSeries B
immatics biotechnologies	Aug 2019Led	$75 MOther Equity
Oncorus	Aug 2019Participated	$80 MSeries B
Cleave Therapeutics	Aug 2019Led	$12 MOther Equity
Aitia	Jul 2019Participated	$23 MSeries D
Rapt Therapeutics	Jun 2019Participated	$37 MSeries C
Vividion Therapeutics	Apr 2019Participated	$82 MSeries B
Arrakis Therapeutics	Apr 2019Participated	$75 MSeries B
HiberCell	Feb 2019Participated	$61 MSeries A
Ikena Oncology	Jan 2019Led	$80 MOther Equity
Biond Biologics	Jan 2019Participated	$17 MSeries B
Cyteir Therapeutics	Oct 2019Participated	$40 MSeries B
Anokion	Sep 2019Participated	$40 MSeries B
immatics biotechnologies	Aug 2019Led	$75 MOther Equity
Oncorus	Aug 2019Participated	$80 MSeries B
Cleave Therapeutics	Aug 2019Led	$12 MOther Equity
Aitia	Jul 2019Participated	$23 MSeries D
Rapt Therapeutics	Jun 2019Participated	$37 MSeries C
Vividion Therapeutics	Apr 2019Participated	$82 MSeries B
Arrakis Therapeutics	Apr 2019Participated	$75 MSeries B
HiberCell	Feb 2019Participated	$61 MSeries A
Ikena Oncology	Jan 2019Led	$80 MOther Equity
Biond Biologics	Jan 2019Participated	$17 MSeries B

60 Items

60

Items

...

Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Celgene: 60 funding rounds are recorded in the selected participation categories. All available history
Round type	Led deals	Participated deals
Series A	2	11
Series B	2	18
Series C+	1	11
Other Equity	10	5

Monthly Deal Activity

Celgene: 60 deals are recorded across 203 months. All available history
Month	Deals
Dec '09	1
Jan '10	0
Feb '10	0
Mar '10	0
Apr '10	0
May '10	0
Jun '10	0
Jul '10	0
Aug '10	0
Sep '10	0
Oct '10	0
Nov '10	0
Dec '10	0
Jan '11	0
Feb '11	0
Mar '11	0
Apr '11	0
May '11	0
Jun '11	0
Jul '11	0
Aug '11	0
Sep '11	0
Oct '11	0
Nov '11	1
Dec '11	2
Jan '12	0
Feb '12	1
Mar '12	0
Apr '12	0
May '12	0
Jun '12	0
Jul '12	1
Aug '12	0
Sep '12	0
Oct '12	0
Nov '12	0
Dec '12	0
Jan '13	0
Feb '13	0
Mar '13	1
Apr '13	0
May '13	0
Jun '13	0
Jul '13	0
Aug '13	0
Sep '13	0
Oct '13	0
Nov '13	0
Dec '13	2
Jan '14	1
Feb '14	0
Mar '14	0
Apr '14	0
May '14	0
Jun '14	1
Jul '14	0
Aug '14	0
Sep '14	0
Oct '14	0
Nov '14	0
Dec '14	1
Jan '15	1
Feb '15	0
Mar '15	0
Apr '15	2
May '15	0
Jun '15	0
Jul '15	0
Aug '15	0
Sep '15	0
Oct '15	0
Nov '15	1
Dec '15	1
Jan '16	1
Feb '16	1
Mar '16	0
Apr '16	2
May '16	2
Jun '16	0
Jul '16	1
Aug '16	1
Sep '16	1
Oct '16	0
Nov '16	0
Dec '16	1
Jan '17	1
Feb '17	2
Mar '17	0
Apr '17	0
May '17	1
Jun '17	1
Jul '17	1
Aug '17	1
Sep '17	0
Oct '17	0
Nov '17	1
Dec '17	1
Jan '18	0
Feb '18	1
Mar '18	2
Apr '18	0
May '18	1
Jun '18	0
Jul '18	2
Aug '18	0
Sep '18	1
Oct '18	1
Nov '18	0
Dec '18	0
Jan '19	6
Feb '19	1
Mar '19	0
Apr '19	2
May '19	0
Jun '19	1
Jul '19	1
Aug '19	3
Sep '19	1
Oct '19	1
Nov '19	0
Dec '19	0
Jan '20	0
Feb '20	0
Mar '20	0
Apr '20	0
May '20	0
Jun '20	0
Jul '20	0
Aug '20	0
Sep '20	0
Oct '20	0
Nov '20	0
Dec '20	0
Jan '21	0
Feb '21	0
Mar '21	0
Apr '21	0
May '21	0
Jun '21	0
Jul '21	0
Aug '21	0
Sep '21	0
Oct '21	0
Nov '21	0
Dec '21	0
Jan '22	0
Feb '22	0
Mar '22	0
Apr '22	0
May '22	0
Jun '22	0
Jul '22	0
Aug '22	0
Sep '22	0
Oct '22	0
Nov '22	0
Dec '22	0
Jan '23	0
Feb '23	0
Mar '23	0
Apr '23	0
May '23	0
Jun '23	0
Jul '23	0
Aug '23	0
Sep '23	0
Oct '23	0
Nov '23	0
Dec '23	0
Jan '24	0
Feb '24	0
Mar '24	0
Apr '24	0
May '24	0
Jun '24	0
Jul '24	0
Aug '24	0
Sep '24	0
Oct '24	0
Nov '24	0
Dec '24	0
Jan '25	0
Feb '25	0
Mar '25	0
Apr '25	0
May '25	0
Jun '25	0
Jul '25	0
Aug '25	0
Sep '25	0
Oct '25	0
Nov '25	0
Dec '25	0
Jan '26	0
Feb '26	0
Mar '26	0
Apr '26	0
May '26	0
Jun '26	0
Jul '26	0
Aug '26	0
Sep '26	0
Oct '26	0

Sector Breakdown

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Celgene: Health & Life Sciences is the largest displayed sector by deal count (59 deals). All available history
Sector	Deals
Health & Life Sciences	59
Manufacturing	3
Space & Frontier Tech	3
Data, Analytics & IT	2
Hardware & Robotics	1
AI & Machine Learning	1

Deal Size Distribution

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Celgene: 60 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)	Deals
<$5M	1
$5M-$10M	2
$10M-$25M	8
$25M-$50M	22
$50M-$100M	23
$100M-$250M	3
$250M-$500M	1
$500M-$1B	0
$1B+	0

Deals By Geography

Top 5 of 5 regions; European countries are grouped as Europe.

Celgene: United States has the largest recorded deal count among the displayed regions (51 deals). All available history
Region	Deals
United States	51
Europe	4
Canada	3
China	1
Israel	1

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Celgene: 20 co-investors are shown, with Alexandria Venture Investments sharing 10 recorded deals. All available history
Co-investor	Shared deals
Alexandria Venture Investments	10
The Column Group	10
Google Ventures	9
Osage University Partners	8
Kleiner Perkins	7
HBM Healthcare Investments	6
OrbiMed	6
5AM Ventures	5
Canaan Partners	5
Versant Ventures	5
Amgen Ventures	4
ARCH Venture Partners	4
Astellas Venture Management	4
Droia Ventures	4
MPM Capital	4
Nextech Invest	4
Novo Holdings	4
Advent Life Sciences	3
BVF Partners	3
Credit Suisse First Boston Equity Partners	3